from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1259/udgB

LFCtreatmentdescriptionclass of inhibitor

0.057

Amikacinug/mL Amikacintranslation

0.948

Cap5-10ug/mL Capreomycintranslation

0.962

Rox10-50 ug/mL Roxithromycintranslation

0.901

SM2-5 ug/mL Streptomycintranslation

0.083

Tet5-10 ug/mL Tetracyclinetranslation

0.525

Rif0.2-5ug/mL Rifampicintranscription

0.803

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.465

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.541

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.614

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.798

Clofazimine10-13 ug/mL Clofaziminerespiration

0.124

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.065

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.885

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.877

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.294

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.433

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.298

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.849

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.001

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.764

KCN5-20 ug/mL Potassium cyaniderespiration

-0.127

NaN30.2-2 mM Sodium aziderespiration

0.007

Nigericin50 uM Nigericinrespiration

-0.244

TRC10-150 ug/mL Triclosanrespiration

-0.536

TRZ10-25 ug/mL Thioridazinerespiration

-0.728

Valinomycin0.5-10 uM Valinomycinrespiration

0.459

ZnSO42 mM ZnSO4respiration

-0.377

menadione6-10 ug/mL Menadionerespiration

-0.576

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.533

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.531

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.227

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.119

NRP_1Non-replicating persistence stage 1dosRassociated

-0.282

Amp0.2mg/mL AmpicillincellWall

-0.275

Cephalexin20-100 ug/mL CephalexincellWall

0.406

Cerulenin0.32-5 ug/mL CerulenincellWall

0.500

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.193

EMB10-20 ug/mL EthambutolcellWall

0.138

Eta12-40 ug/mL EthionamidecellWall

0.304

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.037

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.203

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.147

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.029

BZA0.12 mg/mL BenzamidearomaticAmides

-0.328

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.129

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.024

H2O24 mM hydrogen peroxideDNAdamaging

0.256

Levo10 ug/mL LevofloxacinDNAdamaging

0.371

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.743

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.029

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.561

UVUV-irradiationDNAdamaging

0.290

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.239

Antimycin12.5-50 ug/mL Antimycin A?

0.059

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.081

PA_110-50 ug/mL Antitubercular compound PA-1?

0.012

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.047

PA8240.2-2 ug/mL PA-824?

-0.771

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.034

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.073

Verapamil50 uM Verapamil?

0.256

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.528

methoxatin10-20 ug/mL Methoxatin?